| Osteoglycin as a potential biomarker of mild kidney function impairment in type 2 diabetes patients S González-Salvatierra, C García-Fontana, F Andújar-Vera, ... Journal of Clinical Medicine 10 (10), 2209, 2021 | 11 | 2021 |
| The contribution of Wnt signaling to vascular complications in type 2 diabetes mellitus R Sanabria-de la Torre, C García-Fontana, S González-Salvatierra, ... International journal of molecular sciences 23 (13), 6995, 2022 | 10 | 2022 |
| Analysis of the Genetic Relationship between Atherosclerosis and Non-Alcoholic Fatty Liver Disease through Biological Interaction Networks F Andújar-Vera, M Ferrer-Millán, C García-Fontana, B García-Fontana, ... International Journal of Molecular Sciences 24 (4), 4124, 2023 | 4 | 2023 |
| Mild hypophosphatasia may be twice as prevalent as previously estimated: an effective clinical algorithm to detect undiagnosed cases T González-Cejudo, JM Villa-Suárez, M Ferrer-Millán, F Andújar-Vera, ... Clinical Chemistry and Laboratory Medicine (CCLM) 62 (1), 128-137, 2024 | 3 | 2024 |
| Identification of potential targets linked to the cardiovascular/Alzheimer’s axis through bioinformatics approaches F Andújar-Vera, C García-Fontana, R Sanabria-de la Torre, ... Biomedicines 10 (2), 389, 2022 | 2 | 2022 |
| Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells S González-Salvatierra, C García-Fontana, J Lacal, F Andújar-Vera, ... Cardiovascular Diabetology 22 (1), 301, 2023 | 1 | 2023 |
| Characterization of genetic variants of uncertain significance for the ALPL gene in patients with adult hypophosphatasia R Sanabria-de la Torre, L Martínez-Heredia, S González-Salvatierra, ... Frontiers in Endocrinology 13, 863940, 2022 | 1 | 2022 |
| Relación genética entre las enfermedades pulmonares de origen ambiental u ocupacional y la osteoporosis: un enfoque bioinformático F Andújar-Vera, C García-Fontana, S González-Salvatierra, ... Revista de Osteoporosis y Metabolismo Mineral 13 (4), 130-136, 2021 | 1 | 2021 |
| Non-Classical Effects of FGF23: Molecular and Clinical Features L Martínez-Heredia, JM Canelo-Moreno, B García-Fontana, ... International Journal of Molecular Sciences 25 (9), 4875, 2024 | | 2024 |
| Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene L Martínez-Heredia, M Muñoz-Torres, R Sanabria-de la Torre, ... Frontiers in Endocrinology 14, 1320516, 2024 | | 2024 |
| Exploring the role of osteoglycin in type 2 diabetes: implications for insulin resistance and vascular pathophysiology S González-Salvatierra, B García-Fontana, L Martínez-Heredia, J Lacal, ... American Journal of Physiology-Endocrinology and Metabolism 325 (5), E649-E660, 2023 | | 2023 |
| Influence of musculoskeletal status on fracture risk in patients with adult hypophosphatasia CALM Del, BV Contreras, E Moratalla-Aranda, T Gonzalez-Cejudo, ... Endocrine Abstracts 90, 2023 | | 2023 |
| Potential role of superoxide dismutase 2 (SOD2) in the prevention of the femoral artery calcification in type 2 diabetes patients B Garcia-Fontana, F Andujar-Vera, C Garcia-Fontana, ... JOURNAL OF BONE AND MINERAL RESEARCH 37, 81-81, 2022 | | 2022 |
| HIPOFOSFATASIA Á Jiménez-Ortas, L Martínez-Heredia, F Andújar-Vera, ... | | |
